Pancreatic Cancer Research

ResearcherChiba UniversityActive in the last 2 years

Yasunori Sato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7189-5126; OpenAlex author ID A5012506063. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Prognosis prediction of PDAC via detection of O-glycan altered extracellular vesicles in perioperative sera. Co-author DOI 10.1111/cas.16341↗
  2. SLCO1B1 Polymorphism Is a Drug Response Predictive Marker for Advanced Pancreatic Cancer Patients Treated With Gemcitabine, S-1, or Gemcitabine Plus S-1. Co-author DOI 10.1097/mpa.0000000000001052↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuko Kitagawa · 1 shared paper, 2024 · strength 0.18
  2. Shutaro Hori · 1 shared paper, 2024 · strength 0.18
  3. Minoru Kitago · 1 shared paper, 2024 · strength 0.18
  4. Yuta Abe · 1 shared paper, 2024 · strength 0.18
  5. Masayuki Tanaka · 1 shared paper, 2024 · strength 0.18
  6. Yutaka Nakano · 1 shared paper, 2024 · strength 0.18
  7. Sho Uemura · 1 shared paper, 2024 · strength 0.18
  8. Tatsuya Kawakami · 1 shared paper, 2024 · strength 0.18
  9. Yasuaki Kabe · 1 shared paper, 2024 · strength 0.18
  10. Shinichi Ohkawa · 1 shared paper, 2018 · strength 0.06
  11. Haruo Iguchi · 1 shared paper, 2018 · strength 0.06
  12. Tatsuya Ioka · 1 shared paper, 2018 · strength 0.06
  13. Teruhiko Yoshida · 1 shared paper, 2018 · strength 0.06
  14. Hiroshi Ishii · 1 shared paper, 2018 · strength 0.06
  15. Masafumi Ikeda · 1 shared paper, 2018 · strength 0.06
  16. Hideki Ueno · 1 shared paper, 2018 · strength 0.06
  17. Junji Furuse · 1 shared paper, 2018 · strength 0.06
  18. Akihito Tsuji · 1 shared paper, 2018 · strength 0.06
  19. Takuji Okusaka · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.